Despite the Trump administration’s stated intent to ensure reliable and affordable IVF treatments, the order lacks substantive measures to achieve these goals.
Experts like Katie Kraschel, Professor of Law and WGSS executive committee member, note that the order primarily calls for a study to identify barriers to IVF access rather than implementing immediate policy changes. Consequently, it neither reduces the high costs associated with IVF- averaging between $12,000 and $14,000 per cycle- nor mandates insurance coverage for these treatments.
Significant policy changes, such as requiring insurance companies to cover IVF, would necessitate legislative action from Congress. However, the current political climate, with Republican lawmakers seeking to reduce health spending and some anti-abortion groups opposing IVF, suggests that such legislative support is unlikely.
As a whole, the executive order is largely symbolic, lacking concrete steps to improve access to IVF treatments. Without actionable policies or legislative backing, the order serves more as a public relations gesture than a meaningful advancement in reproductive healthcare.
Read the full article here.
